Could This Novel Therapy Calm Anxiety for Millions of Americans?
October 07, 2025 | Source: UCSF | by Suzanne Leigh
Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point they rarely leave their home and are unable to work and build meaningful relationships. Standard medications may make little difference.
UCSF neuroscientist Jennifer Mitchell, PhD, develops novel therapeutics for drug and alcohol abuse, PTSD, stress, anxiety, impulsivity, and depression. She believes there’s a treatment that can do more. So far, this experimental drug has shown surprising results.
What is this mystery treatment? It’s the pharmaceutical formulation of LSD.